Clinical Trials Logo

Rejection Lung Transplant clinical trials

View clinical trials related to Rejection Lung Transplant.

Filter by:
  • None
  • Page 1

NCT ID: NCT04536883 Completed - Clinical trials for Rejection Lung Transplant

MICRA - Pilot Study

MICRA
Start date: September 23, 2020
Phase: N/A
Study type: Interventional

Acute cell rejection is a common complication of lung transplantation. The pathological diagnosis is based on the performance of transbronchial biopsies which are associated with a significant risk of potentially severe pneumothorax and hemoptysis. Confocal microscopy performed during bronchial endoscopy provides real-time images of the lungs on a microscopic scale. Thus, it is possible to visualize the alveoli, capillaries and intra-alveolar inflammatory cells. So far, work on the subject has only investigated the ability of this technique to determine the presence of acute cell rejection on post-fibroscopy analysis. Our hypothesis is that the absence of airway inflammation seen during the procedure by confocal microscopy is able to rule out the diagnosis of ACR and avoid the performance of transbronchial biopsies. Our job is to first assess the feasibility of the per-procedure evaluation and determine a decision algorithm. If the result is conclusive, a larger study will be carried out to assess the negative predictive value of this approach for the diagnosis of acute cell rejection.

NCT ID: NCT03850002 Withdrawn - Clinical trials for Lung Transplantation

Lung Clearance Index and Lung Allograft Dysfunction

Start date: March 1, 2019
Phase:
Study type: Observational

The aim of this project is to evaluate the ability of the lung clearance index (LCI) to detect early chronic lung allograft failure (CLAD) in adult lung transplant recipients over a period of 3 years.